Portuguese unit of Santander says it wants to grow organically Private equity firm Lone Star owns 75% of Novo Banco Banco Santander SA said it’s not interested in buying Novo Banco SA, the Portuguese ...

JPMorgan analyst Sofie Peterzens raised the firm’s price target on Banco Santander (SAN) to EUR 6.60 from EUR 5.80 and keeps a Neutral rating on the shares. Published first on TheFly – the ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK750.00. The company’s shares closed yesterday at ...

Advocates wanting Luxembourg’s government to sanction Israel for its war in Gaza could themselves face consequences for wrongly using the Chamber of Deputies’ logo on social networks without ...

US private equity firm Lone Star has indicated to the Portuguese government its plans to sell a 25-30% stake in Novo Banco via an initial public offering (IPO), according to Portugal Finance ...

LISBON (Reuters) - U.S. private equity firm Lone Star has told the Portuguese government that it is likely to sell a 25-30% stake in Novo Banco via an initial public offering, rather than seek a full ...

ST. PAUL (Valley News Live) - Attorney General Keith Ellison announced a settlement with Novo Nordisk that guarantees that all Minnesotans, with or without insurance, can buy Novo Nordisk’s ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

(ABC 6 News) – On Monday, Attorney General Keith Ellison announced a settlement with Novo Nordisk that let’s Minnesotans buy its insulin products for $35 per month. For the next five years ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...